Seattle, WA. — November 21, 2019 — OTCQB: KNWN Know Labs, Inc. unveiled today a first look at its wearable UBAND™ Continuous Glucose Monitor (CGM) along with its companion iPhone App.
Phil Bosua, Know Labs CEO and creator of the UBAND said, “We are making great progress in developing our wearable non-invasive continuous glucose monitor that will improve the lives of people with diabetes and pre-diabetes worldwide. We’re thrilled to show the world our new UBAND design and App.”
Know Labs plans to come to market with its wearable non-invasive UBAND CGM subsequent to FDA approval. The UBAND CGM will connect to its smartphone App via Bluetooth and will feature a 7-day battery life. UBAND will provide people with an easy, pain-free way to monitor their blood glucose levels. The App will be available on both the App Store and Google Play.
See About Know Labs, Inc. and our Safe Harbor Statement for company and regulatory information.